NO952493L - Pyrrolidin- og tiazolidinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene - Google Patents
Pyrrolidin- og tiazolidinderivater, deres fremstilling samt medikamenter inneholdende forbindelseneInfo
- Publication number
- NO952493L NO952493L NO952493A NO952493A NO952493L NO 952493 L NO952493 L NO 952493L NO 952493 A NO952493 A NO 952493A NO 952493 A NO952493 A NO 952493A NO 952493 L NO952493 L NO 952493L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- preparation
- pyrrolidine
- medicaments containing
- thiazolidine derivatives
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 title 3
- 239000003814 drug Substances 0.000 title 1
- 150000003548 thiazolidines Chemical class 0.000 title 1
- 102100021022 Gastrin Human genes 0.000 abstract 1
- 108010052343 Gastrins Proteins 0.000 abstract 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9300075A FR2700167B1 (fr) | 1993-01-07 | 1993-01-07 | Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant. |
| PCT/FR1994/000006 WO1994015954A1 (fr) | 1993-01-07 | 1994-01-03 | Derives de pyrrolidine et thiazolidine, leur preparation et les medicaments les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952493D0 NO952493D0 (no) | 1995-06-21 |
| NO952493L true NO952493L (no) | 1995-06-21 |
Family
ID=9442863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952493A NO952493L (no) | 1993-01-07 | 1995-06-21 | Pyrrolidin- og tiazolidinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5637602A (fr) |
| EP (1) | EP0678098A1 (fr) |
| JP (1) | JPH08505613A (fr) |
| KR (1) | KR960700267A (fr) |
| AU (1) | AU5819194A (fr) |
| CA (1) | CA2152183A1 (fr) |
| FR (1) | FR2700167B1 (fr) |
| HU (1) | HUT73806A (fr) |
| IL (1) | IL108287A0 (fr) |
| NO (1) | NO952493L (fr) |
| NZ (1) | NZ259397A (fr) |
| RU (1) | RU95116357A (fr) |
| WO (1) | WO1994015954A1 (fr) |
| ZA (1) | ZA9431B (fr) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2721608B1 (fr) * | 1994-06-22 | 1996-07-19 | Rhone Poulenc Rorer Sa | Dérivés de thiazolidine, leur préparation et les médicaments les contenant. |
| US6388076B1 (en) | 1995-06-19 | 2002-05-14 | Ontogen Corporation | Protein tyrosine phosphatase-inhibiting compounds |
| US5770620A (en) * | 1995-06-19 | 1998-06-23 | Ontogen Corporation | Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| FR2744362B1 (fr) * | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
| FR2744361B1 (fr) * | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
| FR2744363B1 (fr) * | 1996-02-07 | 1998-02-27 | Rhone Poulenc Rorer Sa | Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif |
| TW442449B (en) | 1996-07-04 | 2001-06-23 | Hoechst Ag | Process for preparing 1,2-dichloroethane by direct chlorination |
| AU7667498A (en) * | 1997-05-30 | 1998-12-30 | Celltech Therapeutics Limited | Anti-inflammatory tyrosine derivatives |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| DE69919334T2 (de) | 1998-02-26 | 2005-08-04 | Celltech Therapeutics Ltd., Slough | Phenylalaninderivate als inhibitoren von alpha4 integrinen |
| GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
| US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9811969D0 (en) | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821222D0 (en) | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
| US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
| US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
| US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
| DE60130910T2 (de) | 2000-04-17 | 2008-07-10 | Ucb Pharma, S.A. | Enamin-derivate als zell-adhäsionsmoleküle |
| US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
| US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
| US6740654B2 (en) | 2000-07-07 | 2004-05-25 | Celltech R & D Limited | Squaric acid derivatives |
| AU2001275724A1 (en) | 2000-08-02 | 2002-02-13 | Celltech R&D Limited | 3-substituted isoquinolin-1-yl derivatives |
| US6697016B1 (en) * | 2002-09-30 | 2004-02-24 | Motorola, Inc. | Self adjustment of a frequency offset in a GPS receiver |
| US6846836B2 (en) * | 2003-04-18 | 2005-01-25 | Bristol-Myers Squibb Company | N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase |
| US8247438B2 (en) * | 2008-02-27 | 2012-08-21 | Neuropill, Inc. | Methods for treating schizophrenia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2659653B1 (fr) * | 1990-03-13 | 1992-05-22 | Rhone Poulenc Sante | Derives de l'uree, leur preparation et les medicaments les contenant. |
| FR2678938B1 (fr) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | Derives de pyrrolidine, leur preparation et les medicaments les contenant. |
-
1993
- 1993-01-07 FR FR9300075A patent/FR2700167B1/fr not_active Expired - Fee Related
-
1994
- 1994-01-03 US US08/448,405 patent/US5637602A/en not_active Expired - Fee Related
- 1994-01-03 KR KR1019950702795A patent/KR960700267A/ko not_active Withdrawn
- 1994-01-03 AU AU58191/94A patent/AU5819194A/en not_active Abandoned
- 1994-01-03 RU RU95116357/04A patent/RU95116357A/ru unknown
- 1994-01-03 JP JP6515745A patent/JPH08505613A/ja active Pending
- 1994-01-03 CA CA002152183A patent/CA2152183A1/fr not_active Abandoned
- 1994-01-03 HU HU9502066A patent/HUT73806A/hu unknown
- 1994-01-03 NZ NZ259397A patent/NZ259397A/en unknown
- 1994-01-03 WO PCT/FR1994/000006 patent/WO1994015954A1/fr not_active Ceased
- 1994-01-03 EP EP94903938A patent/EP0678098A1/fr not_active Ceased
- 1994-01-04 ZA ZA9431A patent/ZA9431B/xx unknown
- 1994-01-06 IL IL10828794A patent/IL108287A0/xx unknown
-
1995
- 1995-06-21 NO NO952493A patent/NO952493L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO952493D0 (no) | 1995-06-21 |
| IL108287A0 (en) | 1994-04-12 |
| NZ259397A (en) | 1996-06-25 |
| FR2700167A1 (fr) | 1994-07-08 |
| FR2700167B1 (fr) | 1995-02-03 |
| WO1994015954A1 (fr) | 1994-07-21 |
| CA2152183A1 (fr) | 1994-07-21 |
| ZA9431B (en) | 1994-08-11 |
| AU5819194A (en) | 1994-08-15 |
| HUT73806A (en) | 1996-09-30 |
| US5637602A (en) | 1997-06-10 |
| RU95116357A (ru) | 1997-06-10 |
| JPH08505613A (ja) | 1996-06-18 |
| HU9502066D0 (en) | 1995-09-28 |
| KR960700267A (ko) | 1996-01-19 |
| EP0678098A1 (fr) | 1995-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO952493L (no) | Pyrrolidin- og tiazolidinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene | |
| AU6358986A (en) | New quinazoline derivatives and a process for their production | |
| FI920503A0 (fi) | Terapeutiska heterocykliska foereningar. | |
| EP0522606A3 (en) | Pyridine derivatives, their production and use | |
| AU5875498A (en) | Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclo oxygenase ii | |
| MY117092A (en) | Chemotherapeutic pyrrolocarbazole derivatives | |
| AU591640B2 (en) | Quinolonecarboxylic acid derivatives | |
| DE69200863D1 (de) | Benzyloxyphenylderivate. | |
| SE8107273L (sv) | 2-oxoazetidinderivat, sett att framstella democh anvendning derav | |
| DE3466988D1 (en) | Pyrimidine derivatives, their preparation and pharmaceutical compositions | |
| TW324009B (en) | Pyrazole condensation ring derivative, its production process and its use as androgen inhibitor | |
| NZ230128A (en) | Dibenzooxepine-pyridinium and -pyrrolo derivatives and pharmaceutical compositions | |
| CA2128202A1 (fr) | Derives alkyles de la trazodone agissant sur le snc | |
| AU570541B2 (en) | Pharmaceutically active piperidine derivatives | |
| FR2473522B1 (fr) | ||
| ATE148699T1 (de) | Herstellung von 2-(2-thienyl)äthylamin und synthese von thieno(3,2-c)pyridinderivaten daraus | |
| EP0432841A3 (en) | Spiro-indoline-oxazine compounds with photochromatic and photosensitizing characteristics and the process for their preparation | |
| DE69200862D1 (de) | N-2-Chlorbenzyl-2-oxo- und N-2-Chlorbenzyl-2,2,-dioxo-1,2,3-Oxathiazolidinderivate, ihre Herstellung und ihre Verwendung in der Synthese von Thieno[3,2-c]pyridinderivaten. | |
| DE3368609D1 (en) | Carbacyclines, process for their preparation and their use as medicines | |
| IE892428L (en) | Use of imidazopyrazole derivatives as analgesics and¹anti-inflammatory agents | |
| LV10289A (lv) | Jauns pentapeptids ta iegusanas panemiens kompozicija sunu augsanas inhibesanai inhibesanas panemiens | |
| EP0176049A3 (en) | Aminoalkylnaphtalene derivatives having pharmacological activities | |
| ES8404358A1 (es) | Un procedimiento para obtener derivados de isoxazolopirimidina. | |
| ES8605253A1 (es) | Procedimiento para la preparacion de compuestos derivados deguanidinotiazol | |
| JPS55104266A (en) | Novel pyridone derivative |